Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); EROS Pod On Track for Approval in Q3/12

June 29, 2012 8:59 AM EDT
Get Alerts PODD Hot Sheet
Price: $43.50 -0.11%

Rating Summary:
    16 Buy, 9 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade PODD Now!
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target of $27.00.

Analyst, William J. Plovanic, said, "We recently traveled with management from Insulet on a non-deal road show and came away with more clarity regarding 2012 catalysts, including the regulatory status of the next generation OmniPod (Eros), potential for margin improvement upon commercialization, and a longer-term view of the product pipeline."

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $20.86 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Canaccord Genuity

Add Your Comment